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1. Introduction 
Deep venous thrombosis (DVT) is rarely identified in children. However, there has been an 
increase in the reported association of DVT with pediatric musculoskeletal infection.1-13 The 
relationship appears to be tied to the rise of community-acquired, Methicillin-resistant 
Staphylococcus aureus (CA-MRSA).5-13 Children who are affected by musculoskeletal infection 
and deep venous thrombosis appear to share similar clinical features. They often require 
intensive care, surgical intervention, and prolonged hospitalization.5,6,9 Pulmonary 
involvement, including pneumonia and septic pulmonary emboli, is frequent.9,11 It is 
possible that the causative organisms have an underlying genetic makeup, such as Panton 
Valentine leukocidin, that potentiates the cascade of clinical features seen in these 
children.6,8,10 This chapter explores the relationship of DVT and pediatric musculoskeletal 
infection through meta-analysis of the medical literature from the past forty years. To the 
extent possible, risk factors and clinical characteristics are evaluated and evaluation and 
treatment strategies are discussed. 
2. Review of literature 
The earliest case report of DVT associated with osteomyelitis was by Horvath et al. in 1971.14 
Including that original case, 58 cases of pediatric DVT associated with musculoskeletal 
infection have surfaced in the medical literature (see table 1).1-19 A decade by decade review 
of the case occurrence reveals an exponential increase in the number of cases reported since 
2000, during which time 51 new cases have been identified. This is compared to one case 
from the 1970s and 3 cases from each decade of the 1980s and 1990s. The largest series, to the 
present, was reported at a single institution, Children’s Medical Center of Dallas, compiled 
from two separate reports with overlapping study periods and included 15 unique cases of 
children with DVT.5,9  Of the four studies that report the incidence of DVT within a series of 
children with musculoskeletal infection, the total number of children with DVT is 32 among 
a total of 430 children reviewed giving an estimated incidence of DVT associated with 
musculoskeletal infection of 7.4%.3,6,8,9 
3. Gender, age, type, and site of infection  
Several trends can be derived from the reported cases in a descriptive manner. Children 
with DVT were noted to be male 34 times out of the 46 cases in which gender was identified 
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Horvath14 1971  1 9 m Osteo. R proximal 
tibia 
MSSA R femoral; popliteal L lower lobe 
infiltrate 
 
Jupiter15 1982  2 12 m Osteo. L humerus MSSA L arm deep Multiple 
infiltrates 
 
    12 f Osteo. L femur,  
R tibia 
MSSA L femoral; popliteal Diffuse infiltrates  
Muhlendahl16 1988  1 12 f Osteo. R distal 
femur 
MSSA R femoral Multiple lung 
emboli 
 
Smith17 1997  2 4 f Osteo. L femur S aureus IVC and femoral Pneumatoceles Death 
    2.5 f Osteo. L ilium S aureus IVC and common iliac Pneumonia  
Letts18 1999  1 11.5 m Osteo. Sacrum MSSA R popliteal; R femoral; 
R atrium 
R middle lobe SPE 
Gorenstein19 2000  3 11 m Osteo. L proximal 
femur 
MSSA L femoral Pneumatoceles Death 
    10 m Osteo. L femoral 
head 
MSSA L femoral Pneumonia, 
empyema 
PneumoT. 
    10 m Osteo. L femoral 
neck 
S aureus L iliac Multiple 
infiltrates 
 
Walsh2 2002  4 11 m Osteo. L distal 
fibula 
MSSA L femoral; popliteal Bil. patchy 
infiltrates 
ICU 
    4 f Osteo. L femur,  
R tibia 
S aureus IVC; L common 
femoral 
patchy infiltrates Death 
    2.5 f Osteo. L ilium S aureus IVC; common iliac Pneumonia ICU 
    6 f Pyom. L soleus GABHS L popliteal; peroneal Unknown Comp. sy. 
Newgard1 2002  1 12 m Osteo. Sacroiliac MSSA R common iliac SPE  
Martinez-
Aguilar3 
2004 59 5 U U Osteo. Unkown MRSA Unkown Unknown PVL 
    U U Osteo. Unkown MRSA Unkown Unknown PVL 
    U U Osteo. Unkown MRSA Unkown Unknown PVL 
    U U Osteo. Unkown MRSA Unkown Unknown PVL 
    U U Osteo. Unkown MSSA Unkown Unknown PVL 
Yuksel4 2004  1 3 m Osteo. R distal 
fibula 
S aureus R external iliac Bil. Densities; 
cavities 
 
Gonzalez6 2006 116 9 12 m Osteo. R ilium MSSA R deep pelvic Clear  
    3 m Osteo. R femur MRSA R common femoral; 
external iliac 
Clear PVL 
    3 m Osteo. R tibia MSSA R femoral; popliteal Clear  
    10 m Osteo. L ischium, 
pubis  
& ilium 
MRSA L common iliac Bilateral infiltrates PVL; CVC 
    14 m Osteo. R femur  
and tibia 
MRSA R femoral; popliteal SPE PVL; CVC 
    13 m Osteo. L femur  
and tibia 
MRSA L saphenous Pleural effusions PVL; CVC 
    14 m Osteo. L tibia MRSA L popliteal; saphenous SPE PVL 
    11 m Osteo. L femur MRSA L femoral vein SPE PVL; CVC 
    14 m Osteo. R femur MRSA R common femoral; 
popliteal 
SPE PVL; CVC 
Crary5; 
Hollmig9 
2006/7 352 15 13 m Osteo. R distal 
femur 
MRSA SVC Clear CVC 
    13 m Osteo. R proximal 
fibula 
MRSA R femoral; popliteal Clear CVC 
    9 m Osteo. R proximal 
tibia 
MRSA R femoral; popliteal SPE CVC 
    11 f Osteo. L distal 
femur 
MRSA L femoral; popliteal SPE CVC 
    12 m Osteo. R proximal 
tibia 
MRSA SVC; L internal jugular; 
subclavian 
Clear CVC 





    13 m Osteo. R distal 
femur 
MSSA R femoral; popliteal Unknown CVC 
    7 m Osteo. Thoracic 
spine 
MRSA Azygous; IVC SPE CVC 
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    10 m Osteo. R proximal 
femur 
MRSA R femoral SPE CVC 
    2 m Osteo. R proximal 
tibia 
MRSA R femoral; external 
iliac; saphenous 
SPE CVC 
    14 m Osteo. L distal 
femur 
MSSA L popliteal SPE CVC 
    4 m Osteo. L proximal 
tibia 
C. Tropicalis L popliteal Unknown CVC 
    6 f Osteo. L distal tibia, 
L distal 
femur 
MRSA IVC and SVC Unknown CVC 
    8 f Pyom. L calf Strep. MilleriL posterior tibial Clear  
    6 f Sep. 
Art. 
L hip GABHS R IJ; Sigmoid; 
transverse sinues 
Clear  
Castaldo7 2007  1 U U Sep. 
Art. 
Hip MRSA Unkown Necrotizing 
pneumonia 
 
Dohin8 2007 39 3 U U U Unknown S aureus Unkown Unknown PVL 
    U U U Unknown S aureus Unkown Unknown PVL 
    U U U Unknown S aureus Unkown Unknown PVL 
Mitchell10 2007  3 9 m Osteo. R proximal 
femur 
MSSA L femoral; bilateral IJs; 
R brachial 
Unknown ICU; PVL  
    9 m Osteo. R proximal 
femur 
S aureus R femoral Bilateral infiltrates ICU; PVL  
    13 m Osteo. R femur  
and tibia 
S aureus Unkown SPE PVL 
Nourse11 2007  2 1 m Osteo. L femur MRSA L superficial/common 
femoral; iliac 
SPE PVL 
    13 m Osteo. L proximal 
femur 
MRSA L superficial/common 
femoral 
SPE PVL 
Gite12 2008  3 8 U Osteo. R femur No growth Unkown Unknown  
    6 U Osteo. L femur EnterococcusUnkown Unknown  
    13 U Osteo. L femur S aureus Unkown Unknown  
McDonald13 2010  1 5 m Osteo. R proximal 
humerus 
MRSA R subclavian; brachial; 
cephalic 
SPE ICU 
DVT-Deep vein thrombosis; y-years; m-Male; f-Female; U-Unknown; Osteo.-Osteomyelitis; R-Right; L-
Left; MSSA-Methicillin Senstive Staph Aureus; Bil.-Bilateral; 
MRSA-Methicillin Resistant Staph Aureus; S-staphyloccocus; GABHS-Group A beta hemolytic 
streptoccocci; IVC-Inferior vena cava; SVC-Superior vena cava; 
SPE-Septic pulmonary emboli; PneumoT-Pneumothorax; ICU-Intensive care unit; Comp. sy.-
Compartment syndrome; PVL-Panton-Valentine Leukocidin; C. Candida;  
CVC-Central venous catheters; Sep. Art.- Septic Arthritis; Strep.- Streptoccocus; IJ-Internal jugular 
Table 1. Summary of Published Cases of DVT in Patients with Musculoskeletal Infection 
(73.9%).1-19  The average age of the children with DVT in the reviewed studies was 9 years with 
only six children under the age of 4 years among the 49 children with a recorded age (12.2%).1-
19  The type of infection was found to be osteomyelitis in 51 out of the 55 cases (92.7%) in which 
the musculoskeletal infection type was delineated. 1-19 However, two cases of septic arthritis 
and two cases of pyomyositis were also noted.2,7,9 The location of the infection was reported in 
46 out of the 54 children with osteomyelitis and noted to be unifocal in 40 children and 
multifocal in the remaining six (see table 2). The site of osteomyelitis was most commonly 
reported in the femur (26 occurrences), and specifically reported in the proximal femur on 7 
occasions and the distal femur on 6 occasions. The tibia was the second most common location 
of osteomyelitis (13 occurrences) with the proximal tibia specified in 5 cases and the distal tibia 
specified in one case. Overall, the location of the musculoskeletal infection was found to be in 
the pelvis (ilium, ischium, pubis, or sacrum) or lower extremities in 48 out of the 51 cases in 
which the site of infection was reported (94.1%), with the three remaining cases identified in 
the upper extremities (humerus in two children) and thoracic spine.  
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Location Recorded occurrence Percent 
Thoracic spine 1 2% 
Pelvis 
Ilium 5 9% 
Ischium 1 2% 
Pubis 1 2% 
Sacrum 3 6% 
Total 10 
Femur Unspecified 13 25% 
Proximal 7 13% 
Distal 6 11% 
Total 26 
Tibia Unspecified 7 13% 
Proximal 5 9% 
Distal 1 2% 
Total 13 
Fibula 
Proximal 1 2% 
Distal 2 4% 
Total 3 
Total 53 100% 
Multifocal 6 12% 
Table 2. Frequency Distribution of Osteomyelitis Site 
4. Causative organism 
Staphylococcus aureus was found to be the causative organism in 38 of 43 culture positive 
cases (88.4%) and, of those isolates, 18 (47.4%) were identified as Methicillin-resistant 
Staphylococcus aureus. In one series, the rise in recognition of DVT in their practice appeared 
to coincide with the establishment of USA 300 ST8 as the predominant clone of CA-MRSA in 
their community.6   
5. Panton-Valentine leukocidin 
The identification of Panton-Valentine leukocidin (PVL) genes in the isolates of 
Staphylococcus aureus in children with DVT has been reported in several studies.3,6,8,10,11  
These reports suggest that PVL may be associated with enhanced inflammatory response in 
cases of musculoskeletal infection including pneumonia, multifocal osteomyelitis, 
bacteremia, and concurrent pyomyositis, subperiosteal abscesses or intra-osseous abscesses 
requiring surgical debridment.3,6,8,10,11 The advent of rapid PCR technology as a tool to 
identify the presence of PVL may prove valuable in identifying potentially “silent” cases of 
DVT that would otherwise go unrecognized. To this point, however, the technology to 
perform rapid testing to identify the bacterial genetics of the S. aureus isolates is not readily 
available at most institutions. Our meta-analysis identified 20 children out of the 58 reported 
cases with DVT who were found to be PVL positive (34.5%).3,6,8,10,11 
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6. Location of DVT 
Among the 58 children with DVT, the location of occurrence of the DVT was recorded in 45 
cases and was noted to be multi-focal in 22 (48.9%) children (see table 3). 79 specific 
locations of the DVT were recorded with the most common being femoral (25 or 32%); 
popliteal (14 or 18%); iliac (12 or 15%); and inferior vena cava (6 or 8%). Overall, the 
reported incidence of DVT involving a location inclusive of the inferior vena cava, pelvis, or 
lower extremities was 62 of the 79 occurrences (78.5%).  
 
Location of DVT Occurrence   
Sigmoid Sinus 1 1% 
Transverse Sinus 1 1% 
Internal Jugular 4 5% 
Superior Vena Cava 3 4% 
Subclavian 2 3% 
Arm 4 5% 
Atrium 1 1% 
Azygous 1 1% 
Inferior Vena Cava 6 8% 
Iliac 12 15% 
Femoral 25 32% 
Popliteal 14 18% 
Posterior Tibial 1 1% 
Peroneal 1 1% 
Saphenous 3 4% 
Total 79 100% 
Multiple locations reported 22   
Location not reported 13
Table 3. Frequency Distribution of DVT Location 
7. Clinical features 
Several studies have suggested that children with DVT- associated osteomyelitis 
demonstrate a more severe clinical course when compared to children who do not have 
deep venous thrombosis.3,5,6,8,9,10,11 Specifically, children with DVT are more likely to be 
admitted to the intensive care unit (ICU), require more surgical procedures, and have a 
longer hospitalization than their counterparts who do not have DVT but who do have 
similar forms of musculoskeletal infection.2,5,9,10,13,17,19 One study found that children with 
DVT required an average of 2.6 surgical procedures per child and had a mean duration of 
hospitalization of 30.6 days, compared to children without DVT who underwent an average 
of 0.9 surgical procedures per child and were hospitalized an average of 9.5 days.9  The same 
study determined that children with DVT presented with higher inflammatory indices in 
comparison to children who did not have DVT.9 The mean C-reactive protein (CRP) in 
children with DVT was 16.9 mg/dL , compared with only 6.8 mg/dL in children without 
DVT.9  While intuitively it might be thought that children with DVT would have a delay in 
clinical presentation to a healthcare facility, the authors found that there was in fact a 
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shorter duration between the onset of admission for children with DVT compared to those 
without. (5.6 days versus 14.4 days).9 This lends further support to the possibility that 
children with musculoskeletal infection and DVT have a more abrupt onset and rapid 
clinical decline to the point where medical attention is sought. Pulmonary involvement with 
a variety of manifestations including pneumonia, septic pulmonary emboli, cavitary 
pneumatoceles, empyema, and various infiltrates was recorded in 36 of the 58 children with 
DVT (62.1%).1,2,4-7,9-11,13-19 
8. Central venous catheters 
The use of central venous catheters (CVCs) in the treatment of children with 
musculoskeletal infection has raised the concern that these catheters may be associated with 
risk including DVT development. Our review noted the concurrent presence of CVLs in 
several children with DVT, but the conclusions were generally that there was no clear 
relationship.5,6,9 Hollmig et al. found that CVCs were used in all eleven children with 
osteomyelitis and DVT in their series.9 However, there did not appear to be a relationship 
between the location or temporal onset of the DVT to the CVC in their experience.9  
9. Statistical analysis 
We reviewed 19 articles (15 case reports1,2,4,5,7,10-19, three studies pertaining to musculoskeletal 
infection in general3,8,9, and one  study focused on an osteomyelitis population6). In estimating 
the heterogeneity of the three musculoskeletal infection papers (k = 3), we measured the I2 
index as our test of heterogeneity and found the I2 index to be 7.7%. The Cochran’s Q value 
was found to be 2.153 (p = 0.3407). This statistic signifies a degree of heterogeneity between the 
three papers which makes it difficult to derive meaningful conclusions from the summary data 
from these studies. However, this level of heterogeneity is expected considering several factors 
such as different study methodology, different timing of the onset of disease, different disease 
severity and different patient groups.  
The incidence rate of DVT was calculated to compare the difference between an incidence 
rate specific to osteomyelitis and the incidence related to musculoskeletal infection in 
general. From our results, the number of DVTs in the three musculoskeletal infection papers 
was 23 with a sample size of 450.3,8,9 Therefore the incidence of DVT in children with 
musculoskeletal infection was 5.1%. However, in the one paper in which osteomyelitis alone 
was considered, the number of DVTs was 9 with a sample size of 116.6  Hence, the incidence 
of DVT with osteomyelitis was 7.8%. Although the differences in incidence could be due to 
different populations being studied, there does appear to be a higher incidence of DVT 
specifically with pediatric osteomyelitis as compared to pediatric musculoskeletal infection 
in general. Further research is required in this area.  
10. Evaluation recommendations 
Any child with deep musculoskeletal infection, particularly osteomyelitis caused by 
Staphylococcus aureus should be considered at risk for DVT. However, in light of the medical 
literature, a higher index of suspicion should be held for those children with severe clinical 
presentation, including: intensive care unit admission, markedly elevated inflammatory 
indices, lower extremity location of the musculoskeletal infection, need for repeated surgical 
debridement, and pulmonary involvement with infiltrates or septic pulmonary emboli. These 
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children should undergo screening with non-invasive Doppler ultrasound evaluation of the 
extremities in the region of the musculoskeletal infection to look for DVT. If the ability to 
assess the PVL status of the organism is present within any institution, then this should be 
considered whenever Staphylococcus aureus is isolated from bone, joint, or muscle specimens.  
While stratification of the relative risk of DVT may increase the awareness of the treating 
physician of the child’s potential for DVT, it is important not to overlook the rare cases of 
DVT that might occur in children who fall outside of this risk profile, such as those with 
upper extremity locations of infection, infection types other than osteomyelitis, causative 
organisms other than Staphylococcus aureus, or age under 4 years. Whenever the clinical 
suspicion of DVT exists, supplemental imaging should be considered. 
11. Treatment 
Children with DVT and osteomyelitis can be effectively managed with low molecular 
weight heparin. Resolution of the DVT occurs at an average of ten to twelve weeks.5,9  
Follow-up imaging is helpful to ensure resolution of the DVT. In cases refractory to low 
molecular-weight heparin, consideration may be given to placement of an intravascular 
filter. Warfarin is also an option, but requires additional effort in managing the prothrombin 
time (PT) and international normalized ratio (INR) effectively.  
Because children with DVT and osteomyelitis may require repeat surgical procedures, care 
must be taken to appropriately withhold and resume the anticoagulant therapy around 
periods of surgery to avoid bleeding complications.  
12. Conclusions 
Pediatric musculoskleletal infection is associated with the risk for DVT. Risk factors include:  
osteomyelitis; lower extremity location of infection; Staphylococcus aureus, particularly 
MRSA, as the causative organism; age greater than 4 years; markedly elevated inflammatory 
indices; severe clinical illness often requiring intensive care unit admission, intubation, or 
inotrope support; and pulmonary involvement with infiltrates, pneumonia, or septic 
pulmonary emboli. A high index of suspicion should be maintained when risk factors are 
present and appropriate screening imaging should be obtained. One study demonstrated a 
40% rate of DVT when the child was greater than 8 years of age with positive cultures for 
MRSA and an initial CRP of greater than 6 mg/dL.9 Consideration may be given to 
evaluating for the presence of PVL within the bacterial genetics to help further stratify the 
risk of DVT. Whenever DVT is identified, appropriate treatment should be administered in a 
timely manner and the child should be monitored until the point of resolution. The 
anticipated outcome is good. 
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